Fund Number: 4734
Fund Title:
Supporting the Continuum of Care: Building Ryan White Program Grantee
Capacity to Enroll Eligible Clients in Affordable Care Act Health
Coverage Programs
Fund Category:
HIV/AIDS
Description:
Grant Amount: Approximately $1,900,000 is expected to be available annually to fund one grantee.
The
purpose of Supporting the Continuum of Care: Building Ryan White
Program Grantee Capacity to Enroll Eligible Clients in ACA Supported
Health Coverage is to build the capacity of RWHAP grantees and related
providers to provide outreach to PLWH and to screen and enroll eligible
PLWH in expanded health insurance during the annual open enrollment
period beginning in October 2013. The announcement will fund one
Cooperative Agreement to provide technical assistance to accomplish
three main objectives: (1) assess RWHAP grantees’ technical assistance
needs related to building capacity for outreach and enrollment of
minority PLWH into expanded health insurance options; (2) work with
HRSA, CDC, SAMSHA and CMS to assess best practices for minority client
outreach and enrollment activities that would facilitate access to
health care in the Medicaid expansion and Health Insurance Marketplaces
(Exchanges); and (3) work with HHS agencies and national organization
partners to develop strategies, tools, and trainings for RWHAP grantees
to utilize for outreach and enrollment activities.
The
geographic range of the proposal is nationwide and will focus on the
racial and ethnic minority clients currently served by the RWHAP. The
main activities for the three objectives are:
(1) To assess RWHAP
grantees’ technical assistance needs related to building capacity for
outreach and enrollment of minority PLWH into expanded health insurance
options;
(2) To work with HRSA, CDC, SAMSHA and CMS to assess best
practices for minority client outreach and enrollment activities that
would facilitate access to health care in the Medicaid expansion and
Health Insurance Marketplaces (Exchanges);
(3) Work with HHS
agencies and national organization partners to develop strategies,
tools, and trainings for RWHAP grantees to utilize for outreach and
enrollment activities.
Sponsor(s):
US Department of Health and Human Services
Public Health Service
Health Resources and Services Administration
Funder's Fund ID: HRSA-13-281
Web Page: www.grants.gov/search/search.do;jsessionid=wyKwRSKLCrm1x13QvNJW1GS6LYC1ZL9QBJS3B5nqqznvq0tKLDwk!35997878?oppId=236913&mode=VIEW
Application Due Date: 07/29/2013
Project Start Date: 09/29/2013
Fund Duration: 3 years.
Application Process:
HRSA
requires applicants for this funding opportunity announcement to apply
electronically through Grants.gov. The registration and application
process protects applicants against fraud and ensures that only
authorized representatives from an organization can submit an
application. Applicants are responsible for maintaining these
registrations, which should be completed well in advance of submitting
an application. All applicants must submit in this manner unless they
obtain a written exemption from this requirement in advance by the
Director of HRSA’s Division of Grants Policy. Applicants must request an
exemption in writing from DGPWaivers@hrsa.gov,
and provide details as to why they are technologically unable to submit
electronically through the Grants.gov portal. If requesting a waiver,
include the following in the e-mail request: the HRSA announcement
number for which the organization is seeking relief, the organization’s
DUNS number, the name, address, and telephone number of the organization
and the name and telephone number of the Project Director as well as
the Grants.gov Tracking Number (GRANTXXXX) assigned to the submission
along with a copy of the “Rejected with Errors” notification as received
from Grants.gov. HRSA’s Division of Grants Policy is the only office
authorized to grant waivers. HRSA and its Digital Services Operation
(DSO) will only accept paper applications from applicants that received
prior written approval. However, the application must still be submitted
by the deadline. Suggestion: submit application to Grants.gov at least
two days before the deadline to allow for any unforeseen circumstances.
Number of Awards: 1 award
Award Notes:
Approximately
$1,900,000 is expected to be available annually to fund one grantee.
Applicants may apply for a ceiling amount of up to $1,900,000 per year.
The project period is three years. Funding beyond the first year for
this program is dependent on the availability of funds in subsequent
fiscal years, grantee satisfactory performance, and a decision that
continued funding is in the best interest of the Federal Government.
Eligible Locations:
- National
Application Contact Address:
Grants.gov Contact Center
United States
Email: support@grants.gov
Phone: -
Fax: -
Technical Contact Name:
Heather Hauck
Title: Director
Technical Contact Address:
Div of State HIV/AIDS Program
HIV/AIDS Bureau
United States
Email: hhauck@hrsa.gov
Phone: -
Fax: -
Support Types:
- Cooperative Agreements
Subject Areas:
- Health Care Policies
- Health Care Programs/Services
- Health Insurance
- Minorities
- Outreach
- Persons with HIV/AIDS
- Technical Assistance
- Training Programs
Audiences:
- Local Government Agencies
- State Government Agencies
Eligibility:
- Community Based Organizations
- County Agencies
- IRS 501 (c)(3) Organizations
- Nonprofit Organizations
- Religious Organizations
- State Agencies
Eligibility Notes:
Entities
that are eligible to apply include public groups, nonprofit, private
entities (including faith-based and community based organizations) and
school and academic health science centers involved in addressing
HIV/AIDS related issues at a national level.
Preferred
applicants should have experience developing and disseminating
informational materials, and of providing capacity building assistance
to HIV/AIDS related organizations and constituencies on a national
level. The applicant’s proposal must include a national scope of work.
Fund Number: 4735
Fund Title: Sexually Transmitted Infections Cooperative Research Centers (STI CRC) (U19)
Fund Category:
STD
Description:
Grant Amount: The NIAID intends to commit $11 million total costs in FY 2014 to fund up to five awards.
The
purpose of the Sexually Transmitted Infections Cooperative Research
Centers (STI CRC) program is to facilitate multidisciplinary,
synergistic collaborations that will increase our understanding and
further our knowledge of co-infections of two or more specific STIs, as
well as the interactions between and among different STI pathogens that
may cause or enhance polymicrobial infections of the urogenital tract,
e.g., bacterial vaginosis (BV), pelvic inflammatory disease (PID),
intraamniotic infection (IAI) and non-gonococcal urethritis (NGU). This
collaborative effort is expected to catalyze the discovery of new
approaches to prevent, diagnose, and treat co-infections, polymicrobial
infections and other clinical outcomes that affect reproductive health.
The
objectives of this FOA are to support a group of STI CRCs to engage in a
multidisciplinary, diverse set of STI research activities and to
encourage new efforts towards understanding co-infections of known STIs,
as well as infections that incorporate several pathogens (polymicrobial
infections) and present as specific syndromes, for example pelvic
inflammatory disease (PID). Basic, translational and/or clinical
research is acceptable provided it addresses the purpose of this FOA.
It
is anticipated that these efforts will provide insights into the
biology of microbes, their interactions with each other, their role in
pathogenesis, and their interactions with the host. To this end, the STI
CRCs are encouraged to build upon current knowledge, i.e., to utilize
data from existing microbiome studies to better define the role of
normal flora in STIs; to develop and evaluate control and prevention
strategies to reduce the public health impact of STI infections; and to
share expertise in order to maintain a vigorous and productive research
agenda. An important corollary objective is the training and mentoring
of investigators new to the STI field through the establishment and
management of pilot Developmental Research Projects.
Topics that
would be considered responsive include the study of co-infections,
e.g., organisms that present in association with each other or other
STIs and are often treated syndromatically versus specifically, as well
as polymicrobial infections of the urogenital tract, e.g., bacterial
vaginosis (BV), pelvic inflammatory disease (PID), intraamniotic
infection (IAI) and non-gonococcal urethritis (NGU).
Sponsor(s):
National Institute of Allergy and Infectious Diseases
Division of Microbiology and Infectious Diseases
Funder's Fund ID: RFA-AI-13-043
Web Page: grants.nih.gov/grants/guide/rfa-files/RFA-AI-13-043.html
Letter of Intent Date: 09/23/2013
Application Due Date: 10/23/2013
Project Start Date: 07/01/2014
Fund Duration: Up to 5 years.
Application Process:
Applicants
can access the SF424 (R&R) application package associated with this
funding opportunity using the “Apply for Grant Electronically” button
in this FOA or following the directions provided at Grants.gov.
It is critical that applicants follow the instructions in the SF424 (R&R) Application Guide (http://grants.nih.gov/grants/funding/424/SF424_RR_Guide_General_Adobe_VerB.pdf),
except where instructed in this funding opportunity announcement to do
otherwise. Conformance to the requirements in the Application Guide is
required and strictly enforced. Applications that are out of compliance
with these instructions may be delayed or not accepted for review.
Number of Awards: Up to 5 awards
Award Notes:
The
NIAID intends to commit $11 million total costs in FY 2014 to fund up
to five awards. Future year amounts may vary depending on annual
appropriations.
Eligible Locations:
- National
Application Contact Address:
GrantsInfo
United States
Email: GrantsInfo@nih.gov
Phone: -
Fax: -
Technical Contact Name:
Carolyn Deal
Technical Contact Address:
Div of Microbiology & Infectious
Diseases
NIAID
United States
Email: cdeal@niaid.nih.gov
Phone: -
Fax: -
Contact Note:
Consult
the Agency Contacts section of the FOA for other contacts for
Application Submission, Peer Review, and Financial/Grants Management.
Support Types:
- Cooperative Agreements
Subject Areas:
- Research Programs
- Sexually Transmitted Diseases (STDs)
- STD Prevention
Audiences:
- Researchers
Eligibility:
- City Agencies
- Colleges/Universities
- Commercial Organizations
- Community Based Organizations
- County Agencies
- Educational Organizations/Institutions
- Federal Government Agencies
- IRS 501 (c)(3) Organizations
- Nonprofit Organizations
- Religious Organizations
- Schools
- State Agencies
- Tribal Organizations
Eligibility Notes:
Eligible
Organizations include: (1) Higher Education Institutions: Public/State
Controlled Institutions of Higher Education; Private Institutions of
Higher Education; The following types of Higher Education Institutions
are always encouraged to apply for NIH support as Public or Private
Institutions of Higher Education: Hispanic-serving Institutions,
Historically Black Colleges and Universities (HBCUs), Tribally
Controlled Colleges and Universities (TCCUs), Alaska Native and Native
Hawaiian Serving Institutions, Asian American Native American Pacific
Islander Serving Institutions (AANAPISIs). (2) Nonprofits Other Than
Institutions of Higher Education: Nonprofits with 501(c)(3) IRS Status
(Other than Institutions of Higher Education); Nonprofits without
501(c)(3) IRS Status (Other than Institutions of Higher Education). (3)
For profit Organizations: Small Businesses, For-Profit Organizations
(Other than Small Businesses). (4) Governments: State Governments,
County Governments, City or Township Governments, Special District
Governments, Indian/Native American Tribal Governments (Federally
Recognized), Indian/Native American Tribal Governments (Other than
Federally Recognized), Eligible Agencies of the Federal Government, U.S.
Territory or Possession. (5) Other: Independent School Districts,
Public Housing Authorities/Indian Housing Authorities, Native American
tribal organizations (other than Federally recognized tribal
governments), Faith-based or Community-based Organizations, Regional
Organizations.
Foreign Institutions: Non-domestic (non-U.S.)
Entities (Foreign Institutions) are not eligible to apply; Non-domestic
(non-U.S.) components of U.S. Organizations are eligible to apply;
Foreign components, as defined in the NIH Grants Policy Statement, are
allowed.
Fund Number: 4736
Fund Title: Innovative Assays to Quantify the Latent HIV Reservoir (R21)
Fund Category:
HIV/AIDS
Description:
Grant Amount: NIAID intends to commit $1.125 million yearly to make 4-6 awards.
The
purpose of this Funding Opportunity Announcement (FOA) is to support
research on new or improved methods for quantifying latently infected
cells in HIV-positive individuals on effective antiretroviral therapy.
Quantifying latent HIV reservoirs is critical to evaluating strategies
to cure HIV infection in vivo. The current gold-standard method involves
a limiting dilution viral outgrowth assay that is slow,
resource-intensive, and relatively imprecise. A molecular assay to
accurately detect replication-competent provirus, or a viral outgrowth
assay with improved efficiency, would facilitate proof-of-concept
studies for curing HIV infection.
The goal of this FOA is to
support research on the development of innovative high-throughput
approaches for quantifying the very low levels of latently infected
cells that persist in HIV-positive individuals on HAART. Ideally, a new
assay is needed that specifically quantifies resting CD4 memory T cells
that contain integrated, replication-competent provirus. The key
challenges to be overcome are (1) the low frequency of these cells (only
about 1 in 106 resting cells contains functional provirus), (2) the
lack of cell surface markers distinguishing latently infected cells from
uninfected cells, and (3) the abundance of defective HIV DNA (only
about 1% of HIV DNA in resting CD4 T cells represents
replication-competent provirus).
Examples of research that would fit within the scope of this FOA include, but are not limited to the following:
modifications to the current viral outgrowth assay to improve throughput, cost, precision, or accuracy;
technologies to adapt the viral outgrowth assay to a miniaturized, high-throughput platform; the
automation
of steps in the viral outgrowth assay protocol; the use of advanced
detection technologies to quantify latent HIV; and the development of a
molecular assay that could serve as a surrogate for the viral outgrowth
assay in quantifying replication-competent latent HIV reservoirs.
Sponsor(s):
National Institute of Allergy and Infectious Diseases
Division of Intramural Research
Funder's Fund ID: RFA-AI-13-038
Web Page: grants.nih.gov/grants/guide/rfa-files/RFA-AI-13-038.html
Letter of Intent Date: 10/13/2013
Application Due Date: 11/13/2013
Project Start Date: 07/01/2014
Fund Duration: Up to 2 years.
Application Process:
Applicants
can access the SF424 (R&R) application package associated with this
funding opportunity using the “Apply for Grant Electronically” button
in this FOA or following the directions provided at Grants.gov.
It is critical that applicants follow the instructions in the SF424 (R&R) Application Guide (http://grants.nih.gov/grants/funding/424/SF424_RR_Guide_General_Adobe_VerB.pdf),
except where instructed in this funding opportunity announcement to do
otherwise. Conformance to the requirements in the Application Guide is
required and strictly enforced. Applications that are out of compliance
with these instructions may be delayed or not accepted for review.
Number of Awards: 4 - 6 awards
Award Notes:
NIAID intends to commit $1.125 million yearly to make 4-6 awards.
Eligible Locations:
- National
- International
Application Contact Address:
GrantsInfo
United States
Email: GrantsInfo@nih.gov
Phone: -
Fax: -
Technical Contact Name:
Karl Salzwedel
Technical Contact Address:
NIAID
United States
Email: salzwedelkd@mail.nih.gov
Phone: -
Fax: -
Contact Note:
Consult
the Agency Contacts section of the FOA for other contacts for
Application Submission, Peer Review, and Financial/Grants Management.
Support Types:
- Research
Subject Areas:
- Antiretroviral Drugs
- HIV Positive Persons
- Research Programs
Audiences:
- Researchers
Eligibility:
- City Agencies
- Colleges/Universities
- Commercial Organizations
- Community Based Organizations
- County Agencies
- Educational Organizations/Institutions
- Federal Government Agencies
- International Agencies
- IRS 501 (c)(3) Organizations
- Nonprofit Organizations
- Religious Organizations
- Schools
- State Agencies
- Tribal Organizations
Eligibility Notes:
Eligible
Organizations include: (1) Higher Education Institutions: Public/State
Controlled Institutions of Higher Education; Private Institutions of
Higher Education; The following types of Higher Education Institutions
are always encouraged to apply for NIH support as Public or Private
Institutions of Higher Education: Hispanic-serving Institutions,
Historically Black Colleges and Universities (HBCUs), Tribally
Controlled Colleges and Universities (TCCUs), Alaska Native and Native
Hawaiian Serving Institutions, Asian American Native American Pacific
Islander Serving Institutions (AANAPISIs). (2) Nonprofits Other Than
Institutions of Higher Education: Nonprofits with 501(c)(3) IRS Status
(Other than Institutions of Higher Education); Nonprofits without
501(c)(3) IRS Status (Other than Institutions of Higher Education). (3)
For profit Organizations: Small Businesses, For-Profit Organizations
(Other than Small Businesses). (4) Governments: State Governments,
County Governments, City or Township Governments, Special District
Governments, Indian/Native American Tribal Governments (Federally
Recognized), Indian/Native American Tribal Governments (Other than
Federally Recognized), Eligible Agencies of the Federal Government, U.S.
Territory or Possession. (5) Other: Independent School Districts,
Public Housing Authorities/Indian Housing Authorities, Native American
tribal organizations (other than Federally recognized tribal
governments), Faith-based or Community-based Organizations, Regional
Organizations, Non-domestic (non-U.S.) Entities (Foreign Institutions).
Foreign
Institutions: Non-domestic (non-U.S.) Entities (Foreign Institutions)
are eligible to apply; Non-domestic (non-U.S.) components of U.S.
Organizations are eligible to apply; Foreign components, as defined in
the NIH Grants Policy Statement, are allowed.
Fund Number: 4737
Fund Title: NIAID Investigator Initiated Program Project Applications (P01)
Fund Category:
HIV/AIDS
Description:
Grant Amount: Unspecified.
This
Funding Opportunity Announcement (FOA) invites Program Project
applications (P01) that address the mission of NIAID as outlined in the
Background section of this FOA. Investigators are encouraged to visit
the NIAID website (http://www.niaid.nih.gov/about/whoweare/planningpriorities/Pages/default.aspx)
for additional information about the research mission and high-priority
research areas of the NIAID. The proposed programs may address
scientific areas relevant to the NIAID mission including the biology,
pathogenesis, and host response to microbes, including HIV; the
mechanisms of normal immune function and immune dysfunction resulting in
autoimmunity, immunodeficiency, allergy, asthma, and transplant
rejection; and translational research to develop vaccines, therapeutics,
and diagnostics to prevent and treat infectious, immune-mediated, and
allergic diseases.
The purpose of Program Project (P01) grants
is to support integrated, multi-project research programs that have a
well-defined, central research focus or objective. The P01 is a
confederation of interrelated research projects, each capable of
standing on its own scientific merit but complementing one another. The
P01 application must include a minimum of two individual research
projects that contribute to the program objective. Each individual
research project should reflect a distinct, separate, scientifically
meritorious research effort led by an independent investigator, the
Project Leader. In addition, the individual projects should be clearly
interrelated and synergistic so that the research ideas, efforts, and
outcomes of the program as a whole will offer a distinct advantage over
pursuing the individual projects separately.
In addition to
individual research projects, applicants may propose one or more shared
cores if needed for the proposed research. Each shared resource core
must be utilized by two or more projects within the program. Both
administrative and scientific cores are allowed. For renewals and
resubmissions, new cores may be proposed and/or existing cores may be
augmented to support the proposed research.
Sponsor(s):
National Institute of Allergy and Infectious Diseases
Division of Intramural Research
Funder's Fund ID: PAR-13-254
Web Page: grants.nih.gov/grants/guide/pa-files/PAR-13-254.html
Application Due Date: 09/25/2013
Application Due Date: 01/25/2014
Application Due Date: 05/25/2014
Project Start Date: 07/01/2014
Project Start Date: 09/01/2014
Project Start Date: 04/01/2015
Fund Duration: Up to 5 years.
Application Process:
Applicants
can access the SF424 (R&R) application package associated with this
funding opportunity using the “Apply for Grant Electronically” button
in this FOA or following the directions provided at Grants.gov.
Most
applicants will use NIH’s ASSIST system to prepare and submit
applications through Grants.gov to NIH. Applications prepared and
submitted using applicant systems capable of submitting electronic
multi-project applications to Grants.gov will also be accepted.
It is critical that applicants follow the instructions in the SF424 (R&R) Application Guide (http://grants.nih.gov/grants/funding/424/SF424_RR_Guide_General_Adobe_VerB.pdf),
except where instructed in this funding opportunity announcement to do
otherwise. Conformance to the requirements in the Application Guide is
required and strictly enforced. Applications that are out of compliance
with these instructions may be delayed or not accepted for review.
Award Notes:
The
number of awards is contingent upon NIH appropriations and the
submission of a sufficient number of meritorious applications.
Application budgets are not limited, but need to reflect the actual needs of the proposed project.
Eligible Locations:
- National
Fund Notes:
If the application is AIDS-related, please see http://grants.nih.gov/grants/funding/submissionschedule.htm#AIDS.
Application Contact Address:
GrantsInfo
United States
Email: GrantsInfo@nih.gov
Phone: -
Fax: -
Technical Contact Name:
Martin Gutierrez
Technical Contact Address:
NIAID
United States
Email: mgutierrez@niaid.nih.gov
Phone: -
Fax: -
Contact Note:
Consult
the Agency Contacts section of the FOA for other contacts for
Application Submission, Scientific/Research, Peer Review, and
Financial/Grants Management.
Support Types:
- Research
Subject Areas:
- Disease Prevention
- HIV
- Research Programs
- Vaccine Development Research
Audiences:
- Researchers
Eligibility:
- City Agencies
- Colleges/Universities
- Commercial Organizations
- Community Based Organizations
- County Agencies
- Educational Organizations/Institutions
- Federal Government Agencies
- IRS 501 (c)(3) Organizations
- Nonprofit Organizations
- Religious Organizations
- Schools
- State Agencies
- Tribal Organizations
Eligibility Notes:
Eligible
Organizations include: (1) Higher Education Institutions: Public/State
Controlled Institutions of Higher Education; Private Institutions of
Higher Education; The following types of Higher Education Institutions
are always encouraged to apply for NIH support as Public or Private
Institutions of Higher Education: Hispanic-serving Institutions,
Historically Black Colleges and Universities (HBCUs), Tribally
Controlled Colleges and Universities (TCCUs), Alaska Native and Native
Hawaiian Serving Institutions, Asian American Native American Pacific
Islander Serving Institutions (AANAPISIs). (2) Nonprofits Other Than
Institutions of Higher Education: Nonprofits with 501(c)(3) IRS Status
(Other than Institutions of Higher Education); Nonprofits without
501(c)(3) IRS Status (Other than Institutions of Higher Education). (3)
For profit Organizations: Small Businesses, For-Profit Organizations
(Other than Small Businesses). (4) Governments: State Governments,
County Governments, City or Township Governments, Special District
Governments, Indian/Native American Tribal Governments (Federally
Recognized), Indian/Native American Tribal Governments (Other than
Federally Recognized), Eligible Agencies of the Federal Government, U.S.
Territory or Possession. (5) Other: Independent School Districts,
Public Housing Authorities/Indian Housing Authorities, Native American
tribal organizations (other than Federally recognized tribal
governments), Faith-based or Community-based Organizations, Regional
Organizations.
Foreign Institutions: Non-domestic (non-U.S.)
Entities (Foreign Institutions) are not eligible to apply; Non-domestic
(non-U.S.) components of U.S. Organizations are not eligible to apply;
Foreign components, as defined in the NIH Grants Policy Statement, are
allowed.
|
|
No comments:
Post a Comment